SSY Group (HK:2005) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SSY Group Limited has announced that their muscle relaxant drug, Cisatracurium Besilate, has received registration approval from China’s National Medical Products Administration to be marketed as a bulk drug. The product is used for muscle relaxation, sedation, and as an auxiliary in general anesthesia. The update aims to keep shareholders and potential investors informed about the company’s latest business developments.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.